Meet Staphylococcus aureus, the ultimate microscopic escape artist that invades, adapts, tricks, and thrives within our ...

The antibody from Chicago-based Immunartes is designed to neutralize the immune-evasive mechanisms of Staphylococcus aureus.

The exact degree of population declines, however, will depend on local hunter harvest and recruitment rates, the report ...

The OECD report highlighted the need for targeted policies to reduce the impact of AMR and noncommunicable diseases and ...

Staphylococcus aureus Bacteremia Market The dynamics of the Staphylococcus aureus Bacteremia market are anticipated to change in the coming years owing to the expected launch of emerging therapies and ...

Testing market is projected to expand steadily over the next decade, rising from an estimated USD 4.3 billion in 2025 to USD ...

Sydney researchers have found that Levofloxacin substantially reduces risk of drug-resistant tuberculosis ... in South Africa and involved the same treatment in children. Together, the two ...

Methicillin-resistant Staphylococcus aureus (MRSA) is becoming an increasingly ... Since tigecycline can be one of the rare treatment options in some multidrug-resistant Gram-negative bacteria ...

HY-133 is under clinical development by HyPharm and currently in Phase I for Methicillin-Resistant Staphylococcus aureus (MRSA) Infections. According to GlobalData, Phase I drugs for ...

In April 2024, the U.S. Food and Drug Administration (FDA) approved Zevtera for three specific treatment indications, and it is the only FDA-approved methicillin-resistant Staphylococcus aureus ...

I remember the first time I heard the time "treatment resistant." It was from a friend as they shared with me their mental health story. As this conversation took place some years before my ...